Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Holders of 5% or more of ABEO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Abeona Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G/A | 9.99%5.00M shares | 0.00 ppfrom 9.99% | Nov 14, 20242 filings | May 15, 2025 | SEC |
| Adage Capital Management, L.P. | 13G/A | 8.78%4.41M shares | – | May 12, 20251 filing | May 12, 2025 | SEC |
| BlackRock, Inc. | 13G | 5.80%2.95M shares | New | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| James Russell Revocable Trust | 13G | 5.30%2.72M shares | New | Sep 30, 20251 filing | Sep 30, 2025 | SEC |
| Suvretta Capital Management, LLC | 13G/A | 5.20%2.68M shares | – | Aug 13, 20251 filing | Aug 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Abeona Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 20255:57 PM ET | James Russell Revocable Trust | 13G | 5.30%2.72M shares | New | Sep 16, 2025 | SEC |
| Aug 13, 20257:53 PM ET | Suvretta Capital Management, LLCand 2 others | 13G/A | 5.20%2.68M shares | – | Jun 30, 2025 | SEC |
| Jul 17, 20257:44 PM ET | BlackRock, Inc. | 13G | 5.80%2.95M shares | New | Jun 30, 2025 | SEC |
| May 15, 20254:40 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%5.00M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| May 12, 20259:00 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 8.78%4.41M shares | – | Mar 31, 2025 | SEC |
| May 1, 20254:13 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 1.70%810.0K shares | –Below 5% | Mar 31, 2025 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%4.43M shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Abeona Therapeutics Inc. shares.
No Form 144 notices for Abeona Therapeutics Inc. are on file.